EDIT
Price
$1.31
Change
-$0.03 (-2.24%)
Updated
Dec 20 closing price
65 days until earnings call
PCSA
Price
$0.85
Change
-$0.09 (-9.57%)
Updated
Dec 20, 04:59 PM (EDT)
Ad is loading...

EDIT vs PCSA

Header iconEDIT vs PCSA Comparison
Open Charts EDIT vs PCSABanner chart's image
Editas Medicine
Price$1.31
Change-$0.03 (-2.24%)
Volume$4.22M
CapitalizationN/A
Processa Pharmaceuticals
Price$0.85
Change-$0.09 (-9.57%)
Volume$400
CapitalizationN/A
EDIT vs PCSA Comparison Chart
Loading...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EDIT vs. PCSA commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDIT is a Hold and PCSA is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (EDIT: $1.31 vs. PCSA: $0.85)
Brand notoriety: EDIT and PCSA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EDIT: 160% vs. PCSA: 47%
Market capitalization -- EDIT: $108.14M vs. PCSA: $2.78M
EDIT [@Biotechnology] is valued at $108.14M. PCSA’s [@Biotechnology] market capitalization is $2.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDIT’s FA Score shows that 1 FA rating(s) are green whilePCSA’s FA Score has 1 green FA rating(s).

  • EDIT’s FA Score: 1 green, 4 red.
  • PCSA’s FA Score: 1 green, 4 red.
According to our system of comparison, both EDIT and PCSA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDIT’s TA Score shows that 4 TA indicator(s) are bullish while PCSA’s TA Score has 2 bullish TA indicator(s).

  • EDIT’s TA Score: 4 bullish, 3 bearish.
  • PCSA’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, EDIT is a better buy in the short-term than PCSA.

Price Growth

EDIT (@Biotechnology) experienced а -9.03% price change this week, while PCSA (@Biotechnology) price change was -23.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

EDIT is expected to report earnings on Feb 26, 2025.

PCSA is expected to report earnings on Mar 28, 2024.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EDIT($108M) has a higher market cap than PCSA($2.78M). EDIT (-87.068) and PCSA (-87.298) have similar YTD gains . PCSA has higher annual earnings (EBITDA): -11.79M vs. EDIT (-222.63M). EDIT has more cash in the bank: 265M vs. PCSA (2.89M). PCSA has less debt than EDIT: PCSA (96.8K) vs EDIT (38.5M). EDIT has higher revenues than PCSA: EDIT (61.8M) vs PCSA (0).
EDITPCSAEDIT / PCSA
Capitalization108M2.78M3,889%
EBITDA-222.63M-11.79M1,889%
Gain YTD-87.068-87.298100%
P/E RatioN/AN/A-
Revenue61.8M0-
Total Cash265M2.89M9,166%
Total Debt38.5M96.8K39,773%
FUNDAMENTALS RATINGS
EDIT: Fundamental Ratings
EDIT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EDITPCSA
RSI
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 13 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
View a ticker or compare two or three
Ad is loading...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAOI37.825.43
+16.76%
Applied Optoelectronics
NBY0.530.03
+5.12%
NovaBay Pharmaceuticals
AU23.900.64
+2.75%
AngloGold Ashanti plc
XFOR0.61N/A
+0.66%
X4 Pharmaceuticals
PRK173.581.04
+0.60%
Park National Corp

PCSA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCSA has been loosely correlated with INO. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PCSA jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCSA
1D Price
Change %
PCSA100%
-9.84%
INO - PCSA
38%
Loosely correlated
-0.27%
ONCO - PCSA
35%
Loosely correlated
-3.64%
EDIT - PCSA
28%
Poorly correlated
-2.24%
BGNE - PCSA
27%
Poorly correlated
+1.02%
VKTX - PCSA
27%
Poorly correlated
+1.83%
More